Search research articles

Search research articles

Related Experiment Videos

Dystroglycan complex in cancer.

P A Brennan¹, J Jing, M Ethunandan

¹Maxillofacial Unit, Department of Head and Neck Surgery, Queen Alexandra Hospital, Portsmouth PO6 3LY, UK. peter.brennan@porthosp.nhs.uk

European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology

|July 17, 2004

Summary

This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Out of this world: can surgery learn from NASA's approach to leadership and safety culture?

Annals of the Royal College of Surgeons of England·2025

Same author

Undergraduate medical student exposure to OMFS, a future workforce concern-a narrative review of the literature.

Annals of the Royal College of Surgeons of England·2025

Same author

Abstracts of the 26th International Workshop on Clinical Pharmacology of HIV, Hepatitis and other Antiviral Drugs 2025, 3-4 September 2025, Amsterdam, the Netherlands.

British journal of clinical pharmacology·2025

Same author

Abstracts of the 26th International Workshop on Clinical Pharmacology of HIV, Hepatitis and other Antiviral Drugs 2025, 3-4 September 2025, Amsterdam, the Netherlands.

British journal of clinical pharmacology·2025

Same author

[Multi-omics analysis of the relationship between oxidative stress-related gene and prostate cancer].

Beijing da xue xue bao. Yi xue ban = Journal of Peking University. Health sciences·2025

Same author

Expert-Level Detection of Epilepsy Markers in EEG on Short and Long Timescales.

NEJM AI·2025

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Dystroglycan (DG) protein abnormalities are linked to cancer progression and spread. Understanding DG interactions in solid tumors is crucial for developing new cancer therapies.

Area of Science:

Biochemistry
Cell Biology
Oncology

Background:

Abnormal interactions between tumor cells, adhesion molecules, and extracellular matrix proteins are key in carcinoma behavior.
Alpha- and beta-dystroglycan (DG) proteins, part of the dystrophin-associated protein complex, are vital for epithelial development, basement membrane formation, and tissue integrity.
Reduced or lost DG expression is observed in various cancers, suggesting its role in tumor invasion and spread.

Purpose of the Study:

To review current knowledge on dystroglycan interactions in the context of solid tumor biology.
To highlight the implications of DG abnormalities in cancer progression and dissemination.

Main Methods:

Literature review of studies on dystroglycan function and expression in cancer.

Related Experiment Videos

Analysis of the role of matrix metalloproteinases (MMPs) in beta-DG degradation and tumor dissemination.

Main Results:

Dystroglycan (DG) expression changes and loss are implicated in tumor invasion and dissemination across multiple cancer types.
Matrix metalloproteinase (MMP) mediated degradation of beta-DG may facilitate tumor cell spread.

Conclusions:

Dystroglycan plays a significant role in maintaining tissue integrity and its dysregulation is linked to cancer progression.
Further research into DG-protein interactions and MMP activity is warranted for potential therapeutic strategies against solid tumors.